Back to CGON
T. Rowe Price Investment Management, Inc. → CGON
T. Rowe Price Investment Management, Inc. CGON Position History
CG Oncology, Inc. • Healthcare
Quarters held
5
Latest value
$476.9M
Q3 2026
Peak value
$476.9M
First seen
Q4 2025
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q4 2025 | $1.7M |
| Q4 2025 | $17.5M |
| Q1 2026 | $454.8M |
| Q2 2026 | $470.1M |
| Q3 2026 | $476.9M |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q3 2026 | $476.9M | 6.73M | — | — |
| Q2 2026 | $470.1M | 6.62M | — | — |
| Q1 2026 | $454.8M | 6.72M | — | — |
| Q4 2025 | $17.5M | 422.6K | — | — |
| Q4 2025 | $1.7M | 41.9K | — | — |
Other funds holding CGON
$605M
$603.6M
$472.7M
$452.7M
$451.7M
$431.2M